cefmenoxime - CISMeF

Preferred Label : cefmenoxime;

MeSH definition : A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.;

CISMeF synonym : 75738-58-8 (Cefmenoxime hydrochloride);

MeSH hyponym : cefmax; Abbott-50192; cefmenoxime hydrochloride; SCE-1365; SCE 1365; SCE1365; Abbott 50192; Abbott50192; Hydrochloride, Cefmenoxime; Cefmenoxime Hydrochloride (2:1);

MeSH CAS label : 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-;

MeSH Related Number : cefmenoxime hydrochloride; 65085-01-0 (Cefmenoxime); 75738-58-8 (HCl (2:1)); NON736D32W;

Registry Number MeSH : 65085-01-0;

Related CAS MeSH : NON736D32W (Cefmenoxime hydrochloride);

Is substance : O;

UNII : KBZ4844CXN;

InChIKey : HJJDBAOLQAWBMH-YCRCPZNHSA-N;

Details

Origin ID

D015281;

UMLS CUI

C0007549;

ATC code(s)
- cefmenoxime [ATC Code]
ATC code(s)
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Cefmenoxime [ICD-11 Extension code]
- Cefmenoxime [LOINC component]
- Cefmenoxime [ICHI extension code]
- Cefmenoxime [NCIt concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
Record concept(s)
- Abbott-50192 [MeSH concept]
- SCE-1365 [MeSH concept]
- cefmax [MeSH concept]
- cefmenoxime [MeSH concept]
- cefmenoxime hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- SK&F 88070 [MeSH Supplementary Concept]
- cefteram [MeSH Supplementary Concept]
- cefteram pivoxil [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Cefmenoxime [ICD-11 Extension code]
- Cefmenoxime [NCIt concept]
- Cefmenoxime [LOINC component]
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]
Validated automatic mappings to BTNT
- Cefmenoxime Hydrochloride [NCIt concept]
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]
- cefmenoxime [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients